Nitrofurantoin

Basic Information

Item Value
DrugBank ID DB00698
Evidence Level L5 (Computational Prediction)
Number of Predicted Indications 100

Predicted Indications (TxGNN)

The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.

# Indication Source
1 rheumatoid arthritis KG + DL
2 autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome KG + DL
3 brain small vessel disease 1 with or without ocular anomalies KG + DL
4 diabetic nephropathy KG + DL
5 brachydactyly-syndactyly syndrome KG + DL
6 colobomatous microphthalmia-rhizomelic dysplasia syndrome KG + DL
7 sclerosing cholangitis KG + DL
8 methemoglobinemia, alpha type KG + DL
9 gout KG + DL
10 methemoglobinemia KG + DL
11 HIV infectious disease KG + DL
12 methemoglobin reductase deficiency KG + DL
13 obsolete familial combined hyperlipidemia KG + DL
14 conjunctivitis KG + DL
15 hypoalphalipoproteinemia KG + DL
16 neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter KG + DL
17 multiple endocrine neoplasia KG + DL
18 feline acquired immunodeficiency syndrome KG + DL
19 simian immunodeficiency virus infection KG + DL
20 congestive heart failure KG + DL
21 conjunctivitis (disease) KG + DL
22 malignant hypertensive renal disease KG + DL
23 malignant renovascular hypertension KG + DL
24 paratenonitis KG + DL
25 bone Paget disease KG + DL
26 calcific tendinitis KG + DL
27 pulmonary hypertension with unclear multifactorial mechanism KG + DL
28 pulmonary hypertension owing to lung disease and/or hypoxia KG + DL
29 chronic pulmonary heart disease KG + DL
30 hypertensive disorder KG + DL
31 Braddock syndrome KG + DL
32 methemoglobinemia due to deficiency of methemoglobin reductase KG + DL
33 myositis KG + DL
34 acute pulmonary heart disease KG + DL
35 thyroid gland disease KG + DL
36 homozygous familial hypercholesterolemia KG + DL
37 Prinzmetal angina KG + DL
38 chronic kidney disease KG + DL
39 chronic renal failure syndrome KG + DL
40 skin disease KG + DL
41 hyperplasia KG + DL
42 toxic diffuse goiter KG + DL
43 end stage renal failure KG + DL
44 subacute thyroiditis KG + DL
45 subacute lymphocytic thyroiditis KG + DL
46 suppurative thyroiditis KG + DL
47 female breast carcinoma KG + DL
48 intracerebral hemorrhage KG + DL
49 selective pituitary resistance to thyroid hormone KG + DL
50 nephrotic syndrome KG + DL

(Showing top 50 of 100 predictions)

Disclaimer

These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.


← Back to Drug Search


Copyright © 2026 藥提醒科技有限公司 (yao.care). 本報告僅供研究參考,不構成醫療建議。

This site uses Just the Docs, a documentation theme for Jekyll.